ecancer

Results of the multiple myeloma study comparing zoledronic acid to clodronate

Prof Gareth Morgan - Institute of Cancer Research, Sutton, UK

25 Jun 2010

The efficacy of bendamustine and rituximab in the treatment of indolent lymphoma diseases

Dr Mathias Rummel - University Hospital, Giessen, Germany

25 Jun 2010

Progress in myeloma survival rates

Professor Jesús San-Miguel - University Hospital of Salamanca, Spain

25 Jun 2010

Personalised and reduced therapy for Hodgkin's lymphoma

Prof Volker Diehl - University of Cologne, Germany

16 Apr 2010

Roundtable discussion on the latest advances in multiple myeloma therapy

Prof Gordon McVie, Prof Thierry Facon, Prof Meletios Dimopoulos, Prof Heinz Ludwig

2 Mar 2010

ASH 2009: Novel agents for multiple myeloma

Dr Shaji Kumar - Hematology, Mayo Clinic, Rochester, USA

1 Mar 2010

ASH 2009: Tackling polyneuropathy associated with bortezomib

Dr Pieter Sonneveld - University Hospital Rotterdam, The Netherlands

1 Mar 2010

ASH 2009: New regimens for elderly multiple myeloma patients

Dr Maria-Victoria Mateos - University Hospital of Salamanca, Spain

1 Mar 2010

ASH 2009: Oral panobinostat and bortezomib for relapsed multiple myeloma

Prof Jesus Fernando San-Miguel - University Hospital of Salamanca, Spain

1 Mar 2010

ASH 2009: New treatments for multiple myeloma

Prof Antonio Palumbo - University of Torino, Italy

1 Mar 2010

ASH 2009: Bortezomib, lenalidomide, liposomal doxorubicin and dexamethasone for multiple myeloma

Prof Andrzej Jakubowiak - University of Michigan Comprehensive Cancer Center, USA

1 Mar 2010

Adult acute lymphoblastic leukaemia

Prof Anthony Goldstone - Director, North London Cancer Network

27 Jan 2010

More from ecancer